Study reports the prevalence of different types of shock in
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A new database analysis of critically ill patients with pneumonia related to COVID-19, is the first study to report the prevalence of different types of shock in patients with COVID-19. The definition of these subgroups may allow therapy to be tailored to the underlying causes of the hemodynamic abnormalities. The study showed the incidence of cardiogenic shock in this population, characterized by low ejection fraction and low cardiac index, to be 10 percent.

This group may benefit from inotropic or mechanical support. Another group with preserved ejection fraction but a low cardiac output may respond to volume expansion treatment. Thus, the study may provide better therapeutic approaches to COVID-19 associated shock. The study authors note that patients with COVID-19 and respiratory failure frequently develop shock, some of which is cardiogenic, a life-threatening condition in which the heart can't pump enough blood to meet the body's needs.

They established a comprehensive prospective database of patients admitted with COVID-19 starting on March 2, 2020, including demographics, clinical features, laboratory values, and clinical outcomes. From that database, patients with shock were identified. Those shock patients who had echocardiograms performed were identified and reviewed, with measurement of ejection fraction (EF) and cardiac index (CI).

Of 1,275 patients hospitalized at HUMC with COVID pneumonia between March 2 and May 31, 2020, 215 had shock requiring vasopressors of whom 156 had echocardiography to assess ventricular function and stroke volume. Mean age was 67, mean ejection fraction 59.5, and mean cardiac index 2.40. The patients were divided into 4 subgroups defined by EF and CI: 15 had low EF and low CI, 8 had low EF and normal CI, 55 had preserved EF and low CI, and 73 had preserved EF and normal CI. Overall hospital mortality was 73 percent. Mortality was highest in the group with low cardiac index and low ejection fraction at 87 percent.

Joseph E. Parrillo, M.D., chair, Heart & Vascular Hospital, HUMC, said, "this study shows the ability of clinical research databases to answer important clinical questions about the possible mechanisms and potential best treatments for our patients with serious diseases such as shock due to COVID-19."